Selection of Quality Indicators in IBD

Integrating Physician and Patient Perspectives

Alain Bitton, Maria Vutcovici, Ellina Lytvyak, Natasha Kachan, Brian Bressler, Jennifer Jones, P. Lakatos, Maida Sewitch, Wael El-Matary, Gil Melmed, Geoffrey Nguyen

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background Variation in clinical practice exists in many aspects of inflammatory bowel disease (IBD) care. Our aim was to develop a comprehensive set of quality indicators (QIs) to be measured in view of improving the quality of IBD care provided in clinical practice. This initiative was part of a global Canadian quality initiative PACE (Promoting Access and Care through Centres of Excellence). Methods A modified RAND appropriateness method was used to identify and rate structure, process, outcome, and patient-derived QIs of IBD care. The process included a comprehensive literature search yielding a broad list of QIs, the online selection of QIs by a core expert panel, the selection of patient-derived QIs from 4 patient focus groups, and the subsequent selection of QIs by a multidisciplinary panel, followed by a moderated in-person multidisciplinary meeting during which each indicator was rated for importance and feasibility of measurement. Predetermined cutoffs for mean score and degree of disagreement were used to select the final list of QIs. Results Forty-five QIs, including 6 that were patient-derived, were selected. Nine structure QIs addressed aspects related to the services and specialist care offered at an IBD unit or clinic. Thirty process indicators included administrative and workflow processes, features related to IBD therapy, surveillance, vaccination, and risk management. Six outcome QIs included measures of healthcare utilization, steroid use, and patient satisfaction. Conclusions Forty-five QIs including patient-derived indicators were selected through an iterative process. These indicators can be used to measure and improve the quality of care provided to IBD patients.

Original languageEnglish
Pages (from-to)403-409
Number of pages7
JournalInflammatory bowel diseases
Volume25
Issue number2
DOIs
Publication statusPublished - Jan 10 2019

Fingerprint

Inflammatory Bowel Diseases
Physicians
Workflow
Quality of Health Care
Risk Management
Focus Groups
Patient Satisfaction
Patient Selection
Vaccination
Steroids
Delivery of Health Care

Keywords

  • Crohn's disease
  • indicators
  • inflammatory bowel disease
  • outcome
  • quality
  • ulcerative colitis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Gastroenterology

Cite this

Bitton, A., Vutcovici, M., Lytvyak, E., Kachan, N., Bressler, B., Jones, J., ... Nguyen, G. (2019). Selection of Quality Indicators in IBD: Integrating Physician and Patient Perspectives. Inflammatory bowel diseases, 25(2), 403-409. https://doi.org/10.1093/ibd/izy259

Selection of Quality Indicators in IBD : Integrating Physician and Patient Perspectives. / Bitton, Alain; Vutcovici, Maria; Lytvyak, Ellina; Kachan, Natasha; Bressler, Brian; Jones, Jennifer; Lakatos, P.; Sewitch, Maida; El-Matary, Wael; Melmed, Gil; Nguyen, Geoffrey.

In: Inflammatory bowel diseases, Vol. 25, No. 2, 10.01.2019, p. 403-409.

Research output: Contribution to journalArticle

Bitton, A, Vutcovici, M, Lytvyak, E, Kachan, N, Bressler, B, Jones, J, Lakatos, P, Sewitch, M, El-Matary, W, Melmed, G & Nguyen, G 2019, 'Selection of Quality Indicators in IBD: Integrating Physician and Patient Perspectives', Inflammatory bowel diseases, vol. 25, no. 2, pp. 403-409. https://doi.org/10.1093/ibd/izy259
Bitton A, Vutcovici M, Lytvyak E, Kachan N, Bressler B, Jones J et al. Selection of Quality Indicators in IBD: Integrating Physician and Patient Perspectives. Inflammatory bowel diseases. 2019 Jan 10;25(2):403-409. https://doi.org/10.1093/ibd/izy259
Bitton, Alain ; Vutcovici, Maria ; Lytvyak, Ellina ; Kachan, Natasha ; Bressler, Brian ; Jones, Jennifer ; Lakatos, P. ; Sewitch, Maida ; El-Matary, Wael ; Melmed, Gil ; Nguyen, Geoffrey. / Selection of Quality Indicators in IBD : Integrating Physician and Patient Perspectives. In: Inflammatory bowel diseases. 2019 ; Vol. 25, No. 2. pp. 403-409.
@article{14061cf42dcd467c9cbd65c2ca7ae4b1,
title = "Selection of Quality Indicators in IBD: Integrating Physician and Patient Perspectives",
abstract = "Background Variation in clinical practice exists in many aspects of inflammatory bowel disease (IBD) care. Our aim was to develop a comprehensive set of quality indicators (QIs) to be measured in view of improving the quality of IBD care provided in clinical practice. This initiative was part of a global Canadian quality initiative PACE (Promoting Access and Care through Centres of Excellence). Methods A modified RAND appropriateness method was used to identify and rate structure, process, outcome, and patient-derived QIs of IBD care. The process included a comprehensive literature search yielding a broad list of QIs, the online selection of QIs by a core expert panel, the selection of patient-derived QIs from 4 patient focus groups, and the subsequent selection of QIs by a multidisciplinary panel, followed by a moderated in-person multidisciplinary meeting during which each indicator was rated for importance and feasibility of measurement. Predetermined cutoffs for mean score and degree of disagreement were used to select the final list of QIs. Results Forty-five QIs, including 6 that were patient-derived, were selected. Nine structure QIs addressed aspects related to the services and specialist care offered at an IBD unit or clinic. Thirty process indicators included administrative and workflow processes, features related to IBD therapy, surveillance, vaccination, and risk management. Six outcome QIs included measures of healthcare utilization, steroid use, and patient satisfaction. Conclusions Forty-five QIs including patient-derived indicators were selected through an iterative process. These indicators can be used to measure and improve the quality of care provided to IBD patients.",
keywords = "Crohn's disease, indicators, inflammatory bowel disease, outcome, quality, ulcerative colitis",
author = "Alain Bitton and Maria Vutcovici and Ellina Lytvyak and Natasha Kachan and Brian Bressler and Jennifer Jones and P. Lakatos and Maida Sewitch and Wael El-Matary and Gil Melmed and Geoffrey Nguyen",
year = "2019",
month = "1",
day = "10",
doi = "10.1093/ibd/izy259",
language = "English",
volume = "25",
pages = "403--409",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Selection of Quality Indicators in IBD

T2 - Integrating Physician and Patient Perspectives

AU - Bitton, Alain

AU - Vutcovici, Maria

AU - Lytvyak, Ellina

AU - Kachan, Natasha

AU - Bressler, Brian

AU - Jones, Jennifer

AU - Lakatos, P.

AU - Sewitch, Maida

AU - El-Matary, Wael

AU - Melmed, Gil

AU - Nguyen, Geoffrey

PY - 2019/1/10

Y1 - 2019/1/10

N2 - Background Variation in clinical practice exists in many aspects of inflammatory bowel disease (IBD) care. Our aim was to develop a comprehensive set of quality indicators (QIs) to be measured in view of improving the quality of IBD care provided in clinical practice. This initiative was part of a global Canadian quality initiative PACE (Promoting Access and Care through Centres of Excellence). Methods A modified RAND appropriateness method was used to identify and rate structure, process, outcome, and patient-derived QIs of IBD care. The process included a comprehensive literature search yielding a broad list of QIs, the online selection of QIs by a core expert panel, the selection of patient-derived QIs from 4 patient focus groups, and the subsequent selection of QIs by a multidisciplinary panel, followed by a moderated in-person multidisciplinary meeting during which each indicator was rated for importance and feasibility of measurement. Predetermined cutoffs for mean score and degree of disagreement were used to select the final list of QIs. Results Forty-five QIs, including 6 that were patient-derived, were selected. Nine structure QIs addressed aspects related to the services and specialist care offered at an IBD unit or clinic. Thirty process indicators included administrative and workflow processes, features related to IBD therapy, surveillance, vaccination, and risk management. Six outcome QIs included measures of healthcare utilization, steroid use, and patient satisfaction. Conclusions Forty-five QIs including patient-derived indicators were selected through an iterative process. These indicators can be used to measure and improve the quality of care provided to IBD patients.

AB - Background Variation in clinical practice exists in many aspects of inflammatory bowel disease (IBD) care. Our aim was to develop a comprehensive set of quality indicators (QIs) to be measured in view of improving the quality of IBD care provided in clinical practice. This initiative was part of a global Canadian quality initiative PACE (Promoting Access and Care through Centres of Excellence). Methods A modified RAND appropriateness method was used to identify and rate structure, process, outcome, and patient-derived QIs of IBD care. The process included a comprehensive literature search yielding a broad list of QIs, the online selection of QIs by a core expert panel, the selection of patient-derived QIs from 4 patient focus groups, and the subsequent selection of QIs by a multidisciplinary panel, followed by a moderated in-person multidisciplinary meeting during which each indicator was rated for importance and feasibility of measurement. Predetermined cutoffs for mean score and degree of disagreement were used to select the final list of QIs. Results Forty-five QIs, including 6 that were patient-derived, were selected. Nine structure QIs addressed aspects related to the services and specialist care offered at an IBD unit or clinic. Thirty process indicators included administrative and workflow processes, features related to IBD therapy, surveillance, vaccination, and risk management. Six outcome QIs included measures of healthcare utilization, steroid use, and patient satisfaction. Conclusions Forty-five QIs including patient-derived indicators were selected through an iterative process. These indicators can be used to measure and improve the quality of care provided to IBD patients.

KW - Crohn's disease

KW - indicators

KW - inflammatory bowel disease

KW - outcome

KW - quality

KW - ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=85059797780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059797780&partnerID=8YFLogxK

U2 - 10.1093/ibd/izy259

DO - 10.1093/ibd/izy259

M3 - Article

VL - 25

SP - 403

EP - 409

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

SN - 1078-0998

IS - 2

ER -